Literature DB >> 23974726

Store-operated Ca2+ channels blockers inhibit lipopolysaccharide induced astrocyte activation.

Jian-Hua Li1, Shen-Ting Zhao, Cui-Ying Wu, Xiong Cao, Miao-Ru Peng, Shu-Ji Li, Xiao-Ai Liu, Tian-Ming Gao.   

Abstract

The destruction of calcium homeostasis is an important factor leading to neurological diseases. Store-operated Ca(2+) (SOC) channels are essential for Ca(2+) homeostasis in many cell types. However, whether SOC channels are involved in astrocyte activation induced by lipopolysaccharide (LPS) still remains unknown. In this study, we used LPS as an exogenous stimulation to investigate the role of SOC channels in astrocyte activation. Using calcium imaging technology, we first found that SOC channels blockers, 1-[h-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenethyl]-1H-imidazole (SKF-96365) and 2-aminoethyldiphenyl borate (2-APB), inhibited LPS induced [Ca(2+)]i increase, which prompted us to speculate that SOC channels may be involved in LPS induced astrocyte activation. Further experiments confirmed our speculation shown as SOC channels blockers inhibited LPS induced astrocyte activation characterized as cell proliferation by MTS and BrdU assay, raise in glial fibrillary acidic protein expression by immunofluorescence and Western Blot and secretion of interleukin 6 (IL-6) and interleukin 1β (IL-1β) by ELISA. So, our studies showed that SOC channels are involved in LPS-induced astrocyte activation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23974726     DOI: 10.1007/s11064-013-1130-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  75 in total

Review 1.  2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release.

Authors:  Martin D Bootman; Tony J Collins; Lauren Mackenzie; H Llewelyn Roderick; Michael J Berridge; Claire M Peppiatt
Journal:  FASEB J       Date:  2002-08       Impact factor: 5.191

2.  Dynamic assembly of TRPC1-STIM1-Orai1 ternary complex is involved in store-operated calcium influx. Evidence for similarities in store-operated and calcium release-activated calcium channel components.

Authors:  Hwei Ling Ong; Kwong Tai Cheng; Xibao Liu; Bidhan C Bandyopadhyay; Biman C Paria; Jonathan Soboloff; Biswaranjan Pani; Yousang Gwack; Sonal Srikanth; Brij B Singh; Donald L Gill; Donald Gill; Indu S Ambudkar
Journal:  J Biol Chem       Date:  2007-01-15       Impact factor: 5.157

3.  Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential.

Authors:  Annalisa Buffo; Chiara Rolando; Stefania Ceruti
Journal:  Biochem Pharmacol       Date:  2009-09-16       Impact factor: 5.858

4.  Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

Authors:  D Blum-Degen; T Müller; W Kuhn; M Gerlach; H Przuntek; P Riederer
Journal:  Neurosci Lett       Date:  1995-12-29       Impact factor: 3.046

Review 5.  Alexander disease: new insights from genetics.

Authors:  A Messing; J E Goldman; A B Johnson; M Brenner
Journal:  J Neuropathol Exp Neurol       Date:  2001-06       Impact factor: 3.685

6.  Potentiation and inhibition of Ca(2+) release-activated Ca(2+) channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of IP(3) receptors.

Authors:  M Prakriya; R S Lewis
Journal:  J Physiol       Date:  2001-10-01       Impact factor: 5.182

7.  An examination of the secretion-like coupling model for the activation of the Ca2+ release-activated Ca2+ current I(CRAC) in RBL-1 cells.

Authors:  D Bakowski; M D Glitsch; A B Parekh
Journal:  J Physiol       Date:  2001-04-01       Impact factor: 5.182

8.  Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?

Authors:  Krishnan Sriram; Stanley A Benkovic; Meleik A Hebert; Diane B Miller; James P O'Callaghan
Journal:  J Biol Chem       Date:  2004-03-02       Impact factor: 5.157

9.  STIM1 and Orai1 mediate thrombin-induced Ca(2+) influx in rat cortical astrocytes.

Authors:  Claudia Moreno; Alicia Sampieri; Oscar Vivas; Claudia Peña-Segura; Luis Vaca
Journal:  Cell Calcium       Date:  2012-09-01       Impact factor: 6.817

10.  Calcium signaling in neurodegeneration.

Authors:  Philippe Marambaud; Ute Dreses-Werringloer; Valérie Vingtdeux
Journal:  Mol Neurodegener       Date:  2009-05-06       Impact factor: 14.195

View more
  5 in total

1.  Ca2+ signaling as a mechanism of haloperidol-induced cytotoxicity in human astrocytes and assessing the protective role of a Ca2+ chelator.

Authors:  Shu-Shong Hsu; Wei-Zhe Liang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-06-27       Impact factor: 3.000

Review 2.  Calcium release-activated calcium channels and pain.

Authors:  Yixiao Mei; James E Barrett; Huijuan Hu
Journal:  Cell Calcium       Date:  2018-07-29       Impact factor: 6.817

Review 3.  Reactive Astrocytes in Glioblastoma Multiforme.

Authors:  Xiudong Guan; Md Nabiul Hasan; Shelly Maniar; Wang Jia; Dandan Sun
Journal:  Mol Neurobiol       Date:  2018-01-23       Impact factor: 5.590

4.  The Sur1-Trpm4 channel regulates NOS2 transcription in TLR4-activated microglia.

Authors:  David B Kurland; Volodymyr Gerzanich; Jason K Karimy; Seung Kyoon Woo; Rudi Vennekens; Marc Freichel; Bernd Nilius; Joseph Bryan; J Marc Simard
Journal:  J Neuroinflammation       Date:  2016-06-01       Impact factor: 8.322

5.  Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells.

Authors:  Laura Molteni; Laura Rizzi; Elena Bresciani; Roberta Possenti; Pamela Petrocchi Passeri; Corrado Ghè; Giampiero Muccioli; Jean-Alain Fehrentz; Pascal Verdié; Jean Martinez; Robert J Omeljaniuk; Giuseppe Biagini; Anna Binda; Ilaria Rivolta; Vittorio Locatelli; Antonio Torsello
Journal:  Front Pharmacol       Date:  2017-03-30       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.